Soluble and membrane-bound catechol-O-methyltransferase in normal and malignant mammary gland

Cancer Letters

Volumn 144, Issue 1, 1999, Pages 75-84

  Tenhunen, Jukka ^a   Heikkilä, Päivi ^b   Alanko, Arto ^c   Heinonen, Erkki ^a   Akkila, Juha ^a   Ulmanen, Ismo ^a  

^a ORION CORPORATION   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c JORVI HOSPITAL   (Finland)

Author keywords

Cancer; Catechol O methyltransferase; Catecholestrogen; Immunoblotting; Immunohistochemistry

Indexed keywords

CATECHOL ESTROGEN; CATECHOL METHYLTRANSFERASE;

ARTICLE; BREAST; BREAST CANCER; CELL LINE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; RNA, MESSENGER;

EID: 0032774944     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00197-4     Document Type: Article

References (39)

1. Axelrod J., Tomchick R. Enzymatic O-methylation of epinephrine and other catechols. J. Biol. Chem. 233:1958;702-705.
2. Ball P., Knuppen R., Haupt M., Breuler H. Interactions between estrogens and catecholamines. III: studies on the methylation of catechol estrogens, catecholamines and other catechols by the catechol-O-methyltransferase of human liver, J. Clin. Endocrinol. Metab. 34:1972;736-746.
3. Ball P., Knuppen R. Formation, metabolism and physiological importance of catecholestrogens, Am. J. Obstet. Gynecol. 163:1990;2163-2170.
4. Guldberg H., Marsden C. Catechol-O-methyltransferase: pharmacological aspects and physiological role. Pharmacol. Rev. 27:1975;135-206.
5. Tenhunen J., Salminen M., Lundström K., Kiviluoto T., Savolainen R., Ulmanen I. Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur. J. Biochem. 223:1994;1049-1059.
6. Ulmanen I., Peränen J., Tenhunen J., Tilgmann C., Karhunen T., Panula P., Bernasconi L., Aubry J.-P., Lundström K. Expression and intracellular localization of catechol-O-methyltransferase (COMT) in transfected mammalian cells. Eur. J. Biochem. (243):1997;452-459.
7. Weisz J., Fritz-Wolz G., Clawson G.A., Benedict C., Abenroth C., Creveling C.R. Induction of nuclear catechol-O-methyltransferase by estrogen in hamster kidney: implications for estrogen-inducted renal cancer. Carcinogenesis. 19:(7):1998;1307-1312.
8. Ulmanen I., Lundström K. Cell-free synthesis of rat and human catechol-O-methyltransferase: insertion of the membrane-bound form into microsomal membranes. Eur. J. Biochem. 202:1991;1013-1020.
9. Winqvist R., Lundström K., Salminen M., Laatikainen M., Ulmanen I. The human catechol-O-methyltransferase maps to band q11.2 of chromosome 22 and shows a frequent RFLP with BglI, Cytogenet. Cell. Genet. 59:1991;253-257.
10. Grossman M., Emanuel B., Budarf M. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1-q11.2, Genomics. 12:1992;822-825.
11. Tenhunen J. Characterization of the rat catechol-O-methyltransferase gene proximal promoter: identification of a nuclear protein-DNA interaction that contributes to the tissue-specific regulation. DNA Cell Biol. 15:1996;461-473.
12. Tenhunen J., Ulmanen I. Production of rat soluble and membrane-bound catechol-O-methyltransferase forms from bifunctional mRNAs. Biochem. J. 296:1993;595-600.
13. Lundström K., Tenhunen J., Tilgmann C., Karhunen T., Panula P., Ulmanen I. Cloning, expression and structure of catechol-O-methyltransferase, Biochim. Biophys. Acta. 1251:1995;1-10.
14. Inoue K., Creveling K.C. Induction of catechol-O-methyltransferase in the luminal epithelium of rat uterus by progesterone. J. Histochem. Cytochem. 39:1991;823-828.
15. Smit N., Tilgmann C., Karhunen T., Slingerland R., Ulmanen I., Westerhof W., Pavel S. O-methylation of L-DOPA in melanin metabolism and the presence of catechol-O-methyltransferase in melanocytes. Pigment Cell Res. 7:1994;403-408.
16. Feldman J., Reintgen D., Seigler H. Monoamine oxidase and catechol-O-methyltransferase activity in hamster and rat insulinomas. Diabetologia. 17:1979;249-256.
17. Assicot M., Contesso G., Bohuon C. Catechol-O-methyltransferase in breast cancers. Eur. J. Cancer. 13:1977;961-966.
18. Hoffman A., Paul S., Axelrod J. Catechol estrogen synthesis and metabolism by human breast tumors in vitro. Cancer Res. 39:1979;4584-4587.
19. Amin A., Creveling C., Lowe M. Immunohistochemical localization of catechol methyltransferase in normal and cancerous breast tissues of mice and rats. J. Natl. Cancer Inst. 70:1983;337-342.
20. Stack D., Cavalieri E., Rogan E. Catecholestrogens as procarcinogens: depurinating adducts and tumor initiation. Goldstein D., Eisenhofer G., McCarty. Catecholamines. Bringing Basic Science with Clinical Medicine. 1998;833-836 Academic Press, New York.
21. Yager J., Liehr J. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol. 36:1996;203-232.
22. Liehr J. Dual role of oestrogens as hormones and pro-carcinogens: tumor initiation by metabolic activation of estrogens. Eur. J. Cancer Prev. 6:1997;3-10.
23. Service R. New role for estrogen in cancer? Science. 279:1998;1631-1633.
24. Bradford M. rapid and sensitive method for the quantitation of migrogram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:1976;248-254.
25. Lotta T., Vidgren J., Tilgmann C., Ulmanen I., Melen K., Julkunen I., Taskinen J. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry. 34:1995;4202-4210.
26. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acidic guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
27. Sambrook J., Fritsch E., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Sring Harbor Laboratory, Cold Sring Harbour, NY.
28. Lundström K., Salminen M., Jalanko A., Savolainen R., Ulmanen I. Cloning and characterization of human placental catechol-O-methyltransferase cDNA. DNA Cell Biol. 10:1991;181-189.
29. Schneider J., Huh M., Bradlow L., Fishman J. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J. Biol. Chem. 259:1984;4840-4845.
30. van Aswegen C., Purdy R., Wittliff J. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers. J. Steroid Biochem. 32:1989;485-492.
31. Vandewalle B., Lefebvre J. Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol. Cell. Endocrinol. 61:1989;239-246.
32. Schutze N., Vollmer G., Tiemann I., Geiger M., Knuppen R. Catecholestrogens are MCF-7 cell estrogen agonists. J. Steroid Biochem. Mol. Biol. 46:1993;781-789.
33. Fotsis T., Zhang Y., Pepper M., Adlercreutz H., Montesano R., Nawroth P., Schweigerer L. The endogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth. Nature. 368:1994;237-239.
34. Tenhunen J., Salminen M., Jalanko A., Ukkonen S., Ulmanen I. Structure of the rat catechol-O-methyltransferase gene: separate promoters are used to produce mRNAs for soluble and membrane-bound forms of the enzyme. DNA Cell Biol. 12:1993;253-263.
35. Zhu B., Liehr J. Quercetin increased the severity of estradiol-induced tumorigenesis in hamster kidney. Toxicol. Appl. Pharmacol. 125:1994;149-158.
36. Boudikova B., Szumlanski C., Maidak B., Weinshilboum R. Human liver catechol-O-methyltransferase pharmacogenetics. Clin. Pharm. Ther. 48:1985;381-389.
37. Syvänen A.-C., Tilgmann C., Rinne J., Ulmanen I. Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland. Pharmacogenetics. 7:1997;65-71.
38. Lavigne J., Heltzouer K., -Y H. Huang. P. Strickland, D. Bell, O. Selmin, M. Watson, S. Hoffman, G. Comstock, J. Yager, An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer, Cancer Res. 57:1998;5493-5497.
39. Thomson P., Shields P., Freudenheim J., Stone A., Vena J., Marshall J., Graham S., Laughlin R., Nemoto T., Kadlubar F., Ambrosone C. Genetic polymorphism in catechol-O-methyltransferase, menopausal status, and breast cancer risk, Cancer Res. 58:1998;2107-2110.